Dr. Ho is Board Certified in Internal Medicine, Medical Oncology, and Hematology. His clinical and research interests are in pancreatic and upper gastrointestinal cancers, especially the role of anti-angiogenic agents in cancer treatment. His laboratory interests are in angiogenesis, the role of the Ras protein in GI cancer, and the cell protein CD26 as a treatment target in GI cancer.

Education:

• Undergraduate: University of Texas at Austin (Zoology/Chemistry)
• Medical School: Stanford University
• Graduate School: Stanford University (Cancer Biology)

Selected References:

1. Hanawalt, PC, Gee P, and Ho, L. DNA repair in differentiating cells in relation to aging. In Molecular Biology of Aging, CE Finch and TE Johnson, eds (New York: Wiley-Liss), pp 45-51 (1990)

2. Hanawalt, P. C., Gee, P., Ho, L., Mellon, I., and Smith, C. A. Coupling of DNA repair to transcription in mammalian cells. In Proceedings of the Fifth Congress of the Federation of Asian and Oceanian Biologists.

3. Ho, L. and Hanawalt, P. C. Gene-specific DNA repair in terminally differentiating rat myoblasts. Mutation Research 255: 123-141 (1991).